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Why Metagenomics?
Is metagenomics a revolution or a new fad? Metagenomics is tightly
associated with the availability of next-generation sequencing in all its
implementations. The key feature of these new technologies, moving
beyond the Sanger-based DNA sequencing approach, is the depth of nucleotide sequencing per sample.1 Knowing much more about a sample
changes the traditional paradigms of “What is the most abundant?” or
“What is the most significant?” to “What is present and potentially sig
nificant that might influence the situation and outcome?” Let’s take the
case of identifying proper biomarkers of disease state in the context of
chronic disease prevention. Prevention has been deemed as a viable option to avert human chronic diseases and to curb healthcare management costs.2 The actual implementation of any effective preventive measures has proven to be rather difficult. In addition to the typically poor
compliance of the general public, the vagueness of the successful validation of habit modification on the long-term risk, points to the need of
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defining new biomarkers of disease state. Scientists and the public are
accepting the fact that humans are super-organisms, harboring both a
human genome and a microbial genome, the latter being much bigger
in size and diversity, and key for the health of individuals.3,4 It is time to
investigate the intricate relationship between humans and their associated microbiota and how this relationship modulates or affects both
partners.5 These remarks can be expanded to the animal and plant kingdoms, and holistically to the Earth’s biome. By its nature, the evolution
and function of all the Earth’s biomes are influenced by a myriad of interactions between and among microbes (planktonic, in biofilms or host
associated) and the surrounding physical environment.
The general definition of metagenomics is the cultivation-independent
analysis of the genetic information of the collective genomes of the microbes within a given environment based on its sampling. It focuses on
the collection of genetic information through sequencing that can target DNA, RNA, or both. The subsequent analyses can be solely focused
on sequence conservation, phylogenetic, phylogenomic, function, or genetic diversity representation including yet-to-be annotated genes. The
diversity of hypotheses, questions, and goals to be accomplished is endless. The primary design is based on the nature of the material to be analyzed and its primary function (Figure 1).
It All Starts with the Study Design
The goal is not to tell you how to do your science but to emphasize some
aspects of study design that need careful attention because of the char
acteristics of the methodologies used in metagenomic studies. It begins
by identifying the primary objective of the metagenomics project. What
is the main scientific question you are trying to answer? More than one
hypothesis can be tested depending on the scope of the experiment and
the amount of associated data, or metadata, that you collect and use for
your subsequent analyses.
The high-dimensionality characteristic of the metagenomics datasets is challenging and is revolutionizing microbiology analytical meth
odology. What is meant by high-dimensional dataset? Let’s take as an
example the Human Microbiome Project (HMP) 16S ribosomal RNA
(rRNA)-based characterization of 10 sites from the digestive tract of
200 individuals. Such analysis required the collection of over 2000 samples, generating approximately 23 million high-quality sequence reads
that were assigned to 674 taxonomic clades with their respective relative
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abundance per taxonomic level (e.g., from phylum to genus). For example, for the genus Pyramidobacter, the database stores the relative
abundance at each taxonomic level, from the phylum (e.g., “Bacteria |
Synergistetes”), the most inclusive taxonomic level, to the genus (e.g.,
“Bacteria | Synergistetes | Synergistia | Synergistales | Synergistaceae |
Pyramidobacter”), the least inclusive taxonomic level, and all the tax
onomic levels between the two.6 From the same study, four body sites
were further analyzed using whole metagenome shotgun (WMS) sequencing from approximately 100 individuals, generating a trillion nucleotides.6 Another example can be extracted from the work of Giannoukos et al.7 while developing rRNA depletion methodology for fecal
samples. They obtained over 100,000 reads per sample.7 In each example, each sample has a tremendous amount of genotypic and phenotypic
information in addition to the metadata (e.g., age, sex, race, and others). In addition to the nucleotide data, information about other molecules (e.g., lipids, proteins, and metabolites) can be collected; increasing
the complexity and multidimensionality of the dataset. The type of data
collected will determine the type of analyses performed. These analyses
can help answer questions such as: “What are the organisms present?”,
“What can these organisms potentially do?”,’ “What is their metabolic
capability?”, and “How do they influence the host?” (Figure 1). Planning
the structure of samples and metadata acquisition as well as the analysis pipeline to be used, prior to the start of the experiment, will avoid
bottlenecks and optimize utilization of funds.

Fig. 1. Metagenomic analysis process and some of the overarching questions that
can be answered by the different methodologies.
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During the study design phase, investigators need to take into consideration the ethical and legal issues related to metagenomics data collection and analysis. Some of the constrains of metagenomics studies
utilizing human subjects include Institutional Review Boards, informed
consent, and other issues related to the protection of the identifiable
health information of the human subjects (e.g., HIPAA Privacy Rule in the
United States). For examples of consent documentation and standard
operating procedures, the National Institutes of Health HMP has made
those document public and available online ( http://www.hmpdacc.org
).8 It is essential for the consent procedures to accurately state what data
will be gathered, how it will be used, and how it will be stored. All efforts
should be made to secure information and confidentiality of the genetic
material and associated data over time. This includes both the physical storage of the information, data deposition and data sharing, even
when the samples are de-identified. For environmental samples, having
the right of access and sampling permits is critical as geolocation is now
required with the sample data submission to repository. It is important
to point out that any samples collected from a host will contain a significant amount of the host genetic material. The potential contamination
of samples with the host genetic material adds to the complexity of the
metagenomics studies, and sophisticated computational pipelines for
the removal of the contaminating reads are essential to generate meaningful conclusions and, in the case of human subjects, to protect the privacy and confidentiality of the sample donor. Figure 2 shows the impact
of human “contamination” on the amount and quality of the data collected using shotgun sequencing of human samples from 16 different
body sites.8 When working with different models, it should be noted that
the genome of a brown rat is not that much smaller than that of a human (over 3 billion base pairs), and that the corn genome is over 2 billion
base pairs. Although protists and fungi are much smaller, their genomes
are still composed of few million base pairs. The knowledge of your biological system of interest will be critical to optimize the study design.
Have a Statistical Analysis Plan in Place Before Starting
Planning for statistical analysis should be an integral part of the study design. Although many experimental designs can be performed in metagenomics project, there is no single path to a successful strategy. While using metagenomic or metatranscriptomic approaches, it is essential to
refer to the specific needs of each experiment.
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Fig. 2. Impact of quality and human filtering on shotgun metagenomic dataset.
Thorough quality filtering and removal of reads resulting from human DNA contamination was performed on all shotgun metagenomic data of the Human Microbiome Project (average of 13 Gb/sample). The variation in fraction of reads per sample removed across the 18 body sites is shown by (A) boxplots for % of human and
of (B) quality filtered reads. (C) Total amount of usable data (white) per site significantly varied because of (i) the different number of samples per site, (ii) the differential impact of human contamination (dark gray), and (iii) the differential impact
of quality filtering (light gray). (D) Summary view of the usable fractions versus human and quality filtered data, per body site. (Reprinted by permission from Macmillan Publishers Ltd.8)

The statistical analysis plan should take into account the characteris
tics of the experiment (in human studies, this would be the inclusion and
exclusions criteria), the rate of sample acquisition (this would include the
rate of human subject recruitment that will determine if you are working
with one or more batch of datasets), the descriptive objectives, testable

J. I z a r d i n M e t a g e n o m i c s f o r M i c r o b i o l o g y ( 2 0 1 5 )

6

hypotheses, the statistical methods that might be stand alone or imbedded in bioinformatics tools or pipelines, etc. One of the direct advantages
of planning ahead is that when you have the data in hand, you’ll have a
strategy in place to start the analysis. This is critical as next-generation
sequencing provides a tremendous amount of data and you want to remain focused on your primary objective(s). After the accomplishment of
your primary objective(s), exploratory analyses and additional hypotheses investigation or formulation is always a possibility.
The most basic question about the research plan should be “Are
enough samples being collected from each site or from enough subjects to make meaningful conclusions?” To properly assess the degree of
similarity or dissimilarity between bacterial communities, a measurable
difference, or effect size, is necessary. In general, the smaller the effect
size and the greater the variability within a group of samples, the larger
the number of samples is required to achieve adequate statistical power.
For determining sample size for experiments using metagenomic taxonomic data, the work derived from the HMP provided the first available calculation and software package9 (see chapter 6 by La Rosa and
colleagues). For metagenomics and metatranscriptomics, standardized
methods to assess the number of subjects (or independent samples)
and reads are yet to be developed. If you are planning to use both a
16S rRNA gene-targeted approach and whole-metagenome shotgun
sequencing, a two-stage experimental design is an option to focus on a
subset of samples.10
The complexity of your sample will greatly influence the depth of se
quence coverage in WMS and metatranscriptomics sequencing projects. As mentioned above, host genomic information can represent a
significant amount of genetic data obtained through next-generation
sequencing approaches, and this information should be part of an optimized study design.
If the complexity of the sample is low (as determined by more tradi
tional methods), you may be able to estimate the depth of sequencing
coverage needed, in order to sample the whole metagenome. Although
each next-generation sequencing platform has its unique biases and
associated errors (an issue not restricted to next-generation sequencing), metagenomic analyses assume that the reads are sampled randomly, independently, and evenly distributed across all the genomes in
the metagenome.11,12 To calculate the coverage, you need to know the
amount of material (nucleotide amount) you are using and the size of
the genomes or an average size for that environment. Figure 3 provides
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Fig. 3. Distribution of genome size based on temperature and habitat. (A) Distribution of genome sizes among prokaryotes with different growth temperature ranges.
The differences in genome size between mesophiles, thermophiles, and hyperthermophiles are significant (Wilcoxon rank-sum test, P < 1.9 × 10−5 and P < 7.9 × 10−3
for mesophiles–thermophiles and thermophiles–hyperthermophiles, respectively),
but not between psychrophiles and mesophiles (Wilcoxon rank-sum test, P = 0.082).
(B) Distribution of genome sizes among different habitats. Habitats are ordered according to environmental variability from unvarying (host associated) to the most
variable environment (terrestrial). The distributions of genome sizes differ between
habitats (Wilcoxon rank-sum test, P < 0.018, P < 0.0005, P < 0.0028, for specializedaquatic, aquatic-multiple, and multiple-terrestrial, respectively), with the exception
of host-associated habitats (Wilcoxon rank-sum test, P = 0.67, for comparison between host-associated and specialized). The red vertical marks are the medians, the
edges of the box are the 25th and 75th percentiles, the whiskers extend to the most
extreme data points not considered outliers (99% of all data if the data are normally
distributed), and outliers are individually plotted as red crosses. Reprinted by permission from Oxford University Press.16

an overview of expected genome size in prokaryotes that can be complemented by other resources providing the exact information on specific genomes.13–16 The correlation between G+C content and chromosome size can be positive, negative, or not significant depending on the
clade from kingdom to species.15 To our advantage, most chromosomes
within a species have a similar pattern of correlation between G+C content and chromosome size; however, outliers are common.15
Longitudinal studies present their own challenges and can be indepen
dently analyzed at each time point, along the timeline as well as across
body sites17,18 (see chapter 7 in this book). When feasible, the collection
of the metadata in between the time points is also critical in understanding the dynamic signatures of microbial population modification. Pooling the samples might seem to be a good strategy to reduce cost and
reduce sample variation. However, this approach loses all of the low genetic representation and the ability to make inferences about the microbial population.
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You might not find a metagenomic dataset to help or guide you in the
experimental design phase. Instead, previous results using other molecu
lar techniques or culture-based methods might be an alternative source
of help in the design. If you were looking at the same question with a
more traditional method, you should have enough samples to detect dif
ferences if they are present.
Metadata Is Needed to Provide Context to the Analysis
Critical to any metagenomic study is the quality and extent of the contextual metadata. Metadata is what will enhance your analysis beyond
the most obvious evidence. It provides context to the experiments and
allows for meaningful comparisons between studies, while deepening
our understanding of the dataset. With a greater depth of information,
a broader knowledge of the “environmental factors” is needed. Although
not the focus of an experiment, seemingly extraneous data may become
important. For example, information on the source of carbon for mi
crobial metabolism might be later identified as a confounding variable
in an experiment. It can be as simple as the source of sugar intake for a
subject or the nature of the pollutant for a soil sample.
The information about the sample location or its relative position
to other samples can be included in the analyses. The concept of bio
geography goes beyond the description of environmental features that
influence the spatial distribution of the microorganisms. It aims to un
derstand the metabolic processes within the microbes’ own niche and
their relationships with other biological niches. The niche might be the
different sites in the oral cavity, along the digestive tube, or in the skin.19–
21 Large-scale data visualization and analysis tools have been created to
help us better understand these positional aspects22.
As we are discovering the microbiome as an interdependent organ of
any biological system,5 we may need to redefine what are the best as
sociated data to collect along with the genomic sample. Although blood
analyses might reflect the systemic inflammation of a human subject, the
levels of air particles less than 2.5 mm in diameter (PM2.5) that the subject
is exposed to might contribute to the severity of their asthma, modifying
the microbiome, which, in turn, can modify the responsiveness to medication.23,24 In longitudinal datasets, seasons and length of the day have
been shown to influence the ocean microbiome.25
Defining or re-defining the phenotype of interest might have a crucial importance. Because the phenotype is the results of the interaction
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between the genotype and the organism’s environment in all its complexity, including the microbiome, we are required to renew our attention to the granularity of the defined phenotype. From the macro to the
molecular scale, new considerations that were previously neglected because of the lack of significance might be at play when scrutinized with
a different sliver or window of observation. Guidelines for data organization and naming standardization are already in place and are being improved upon, as described below.
Sampling: The Basis of Good Results
Although the technology of the sequencing platforms has evolved, they
all focus on sequencing the nucleic acids, either DNA or RNA. The source
of the microbiome sample greatly varies, from the environment, plants,
insects, and animals to humans. The published data on environmental
samples have been as diverse as soil, hot springs, seawater, air, as well
as home and hospital surfaces. For plants, the associated microbiome
above and below the ground has been studied. In insects, animals, and
humans, multiple body sites have been investigated. In many of the subsequent steps, the hypothesis involved, the goals of the project, the available facilities and personnel, and the available funds play a role in the
decision matrix.
Contamination will be detected as an integral component of the sample because of the depth of the data being acquired. Only a few years
ago, understanding microbial diversity often led the investigator to do
a series of cloning experiments resulting in the identification of approximately 100 randomly selected organisms per sample. Later, the availability of microarrays allowed the identification of few hundreds of organisms
per sample. More recently, by using targeted 16S rRNA gene next-generation sequencing, tens of thousands of organisms can be identified per
sample.1,26 It is recommended to examine each step in the context of potential inadvertent contamination by nucleic material or potential inhibitor for downstream applications. This is particularly applicable to tools
that are reused, where proper cleaning and sterilization procedures are
essential. The following guidelines are simple ways to increase the quality
of sample preparation. Not talking over a biological sample or wearing a
facemask would eliminate contamination by the breath. While protecting
the sample using gloves, we should not forget that a simple touch of the
skin or a surface would contaminate the glove that, in turn, might contaminate the sample itself. Natural DNAses and RNAses may potentially
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damage the sample. It is most often about applying common sense in
the context of the depth of the data to be gathered. In other words, if
you want to know the microbiome of the banana peel on the plant but
you drop the banana in the field, you are going to also learn about the
microbiome of that square of earth as well as that of the fruit.
The proper sampling protocol is essential to a successful metagenom
ics study, since the accurate identification of many organisms depends
on the collection and handling of the sample. Defining the geographical
location or the specific body site, surface, depth volume, or quantity to
be collected are necessary for sampling standardization. When possible,
keep the samples concentrated and process them for immediate storage. Consistency in all aspects will both preserve the quality of the sample and limit the batch effect during the analysis, enhancing the signal
of interest. Protecting the samples against the element (wind, sun, etc.)
sounds to be a good advice, but keep in mind that sample desiccation is
a common problem when working with small samples.
Analyzing true and technical replicates of a sample and assessing
whether observed differences are statistically significant are a good prac
tice. True replicates, when the same site is sampled more than once, are
rarely done in metagenomics study as the sensitivity of the technique
may easily show differences when sampling a site multiple times because
of the biological organization of the site.27 Technical replicates, when the
sample is split for processing, are easy to perform for reassurance.28,29
Sample Storage
Storage and sampling are tightly linked issues. It is not always possible
to have a freezer or an expert on location when the sample is collected.
Solutions for these problems affecting the downstream steps need to
be identified before starting the study. The nature of the type of sample
is too diverse to enter in all the details, but one key question will drive
the process: “How much sample do I really need?” The associated questions would be: “Do I need DNA, RNA, proteins, lipids, small molecules,
etc., from the same sample?”, “Will the sample be used for more than
one application, preparation, or extraction?”, as well as any other questions related to the present or the future study applications that might
be of interest later on.
Many options are available, from immediate extraction to long-term
storage in liquid nitrogen. The nature of the sample often dictates what
is the best protocol to avoid sample desiccation, denaturation, lysis,
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degradation, etc. As immediate extraction on site or access to an −80°C
freezer is not always an option, alternatives must be developed to pre
serve the sample, its integrity, and its value for the question(s) at hand.
Similarly, for a vaccine, the quality of storage and its consistency might
influence the sample quality. Multiple companies are offering sampling
kits with fixative but those are rarely validated by comparative analysis.
A metagenomic and metatranscriptomic comparison of human stools
flash frozen, preserved in ethanol, or in RNA later show that those fixa
tives are compatible with large-scale self-collection by human subjects
in a geographically disseminated cohort.30
Sampling cost is often neglected. You might have multiple steps in
your process to reach the final storage space, and there is no issue with
that. Optimize your process to be the most consistent for each sample
or per batch of samples. It should be stressed that whether you work on
a large human subject cohort or a large field collection, the cost of personnel, sampling equipment (single use when possible), and transient as
well as permanent storage adds up quickly. With the sample collected
and in storage, nucleotide extraction will be the next step.
Sample Extraction
The sample input into a metagenomics pipeline can be extremely diverse. The DNA and/or the RNA need to be extracted from the sample
prior to any analysis. The type and source of the sample determines the
most appropriate extraction protocol. This step, simplified by the availability of nucleic acid extraction kits, is crucial to the success of the analysis, as the quality of extracted DNA and/or RNA influences all subsequent steps. Before selecting the most appropriate extraction protocol,
a careful review of the literature and validation of the protocol for your
specific sample is recommended. The choice of protocol depends on
the DNA or the RNA yield, shearing, removal of contaminants (which
could be inhibitory to subsequent steps), and representation of diversity. A compiled list of extraction protocols for different sample sources
has been recently published.31 Some other criteria have to be taken in
consideration as described below.
As mentioned above, the source of the sample is very important in
the selection of the extraction protocol. A classic example of this is dem
onstrated by the inhibitory effect of humic acids in enzymatic reactions,
such as polymerase chain reaction (PCR), performed using nucleic acids
extracted from manure or soil.32,33 Thus, elimination of humic acids needs
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to be part of the process, which might be already optimized by a compatible specific kit.
How the sample was preserved also matters. An example is the DNA
recovery from formalin-fixed paraffin-embedded tissue, as the tissue is
not readily available to traditional protocols.34,35
Differences in the structures of bacterial cell walls cause bacterial cell
lysis to be more or less efficient.36,37 The differential efficiency of the lysis
can distort the apparent composition of the microbial communities and
introduce bias in estimates of relative abundance.36–39
Consistency in sample handling and processing is key to avoid batch
effect. Training, standard operating procedure, and good quality controls
greatly help in minimizing the possibility of batch effect. Nucleic acids
extraction automation is a good alternative when sufficient samples are
available and the method of extraction has been validated.40
Extracting more than one macromolecule at the time is an option. Kits
and protocols allow the purification of both DNA and RNA from the same
sample, while others go further by recovering proteins as well.31 An ongoing challenge is to purify other macromolecules from the same sample, which might require a different set of strategies.
Removing the host DNA might improve the quality of your analysis
and decrease the cost of the sequencing by requiring magnitude(s) less
of reads for the same amount of information. Differential lysis of eu
karyotic cells (personal communication, Dr Eva Haenssler) and separation
of methylated DNA based on CpG site methylation density between the
host and the microbes41 are the two strategies used by commercial kits.
The attempt to decrease host DNA is not only limited to vertebrate hosts
but successful contaminant DNA removal have also been performed in
plants.42,43
Choosing the Right Platform
The cost of sequencing has drastically decreased (Figure 4), opening
the door to many new investigations that were previously too costly. Al
though the cost per base of sequencing has decreased, the total cost of
a run is still significant because the number of megabases sequenced
per run is steadily increasing (Table 1). The initial entry cost might be
still too high for some pilot projects. Based on those same parameters,
traditional techniques such as PCR-DGGE (PCR followed by a denaturing
gradient gel electrophoresis), cloning experiments followed by Sangerbased DNA sequencing, and microarrays approaches are here to stay.44,45
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Fig. 4. Reduction of the cost of DNA sequencing over time. The white line reflects
the Moore’s Law pace. The Y axis shows, in logarithmic scale, the cost of sequencing
per raw megabase of raw unassembled DNA sequence. The out-pacing of Moore’s
Law pace matches the availability of the first next-generation sequencing platforms,
in 2008, competing with Sanger-based DNA sequencing technology. (Courtesy of
the National Human Genome Research Institute.45)

Which sequencing platform to use? Because of the varied nature of
scientific studies, there is no single approach that is recommended. Detailed review of the literature, discussions with colleagues and sequencing facilities, cost, availability, turnaround time, and scope of the project will be part of the decision-making process. Let’s not forget that the
hypothesis and the goal should be the true drivers. Table 1.1 shows the
characteristics of the different high-throughput sequencing technologies.
Each sequencing platform is characterized by their strength and weaknesses regarding read length, bias in AT- or GC-rich regions and their
ability to sequence homopolymers.46,47
How much sequencing depth is needed? Determining the number
of reads required is a tradeoff between the minimal numbers of reads
needed to allow an informative and statistical significant analysis and
the available budget. This choice is driven by both the platforms and
your experimental needs such as the previous knowledge of the relative
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Table 1. Sequencing Platforms and Characteristics Based on Online Manufacturer Technical Specifications
Sequencer

Read
Length (b)a

Run Time
(h) (d)b

Reads
Yield (b)a
Per Run		

Mate Pair
Use in
Information Metagenomics

ABI 3730xlc

500–900

6–10 h

–

0.05–0.08 Mb

Yes

Not anymore

Roche 454
GS Juniord

∼400

10 h

∼100,000

35 Mb

No

Yes

Roche 454
GS FLX+d

∼700

23 h

1 million

700 Mb

No

Yes

Illumina
MiSeqd

∼300

5–65 h

25 million

0.3–15 Gb

Yes

Yes

Illumina
∼300
12-30 h
NextSeq 500			

130–400
million

20–120 Gb

Yes

Yes

Illumina
∼125–150
7 h to 6 d
HiSeq 2500d			

300 million
to 2 billions

10–180 Gb

Yes

Yes

Illumina
HiSeq Xd

∼150

<3 d

3 billions

1.6–1.8 Tb

Yes

Not yet

5500 SOLiDd

∼60

7d

–

90 Gb

Yes

Yes

7d

–

300 Gb

Yes

Yes

Ion PGM
∼200 or
2–4 h or
systeme
∼400
4–7 h
			
			
			
			

0.4–0.5 million
on 314 chip
2–3 million
on 316 chip
4–5.5 million
on 318 chip

30–100 Mb
on 314 chip
300 Mb to 1 Gb
on 316 chip
600 Mb to 2 Gb
on 318 chip

No

Yes

PacBio
4200–8500 0.5–3 h
RS II SMRTe			

50,000
per cell

275–375 Mb
per cell

No

Yes

5500xl SOLiDd

∼60

a. b stands for base and its multiple
b. h: hours; d: days
c. First-generation DNA sequencing or Sanger-based DNA sequencing technology. ABI 3730xl: Applied Biosystems 3730xl DNA
Analyzer (Life Technologies Corporation, Carlsbad, CA).
d. Second-generation DNA sequencing. Roche 454 GS Junior and Roche 454 GS FLX+ systems from Roche Diagnostics Corporation (454 Life Sciences, Branford, CT). Illumina MiSeq, HiSeq 2500 and HiSeq X from Illumina, Inc. (San Diego, VA). 5500
and 5500xl SOLiD sequencer from Life Technologies Corporation (Carlsbad, CA).
e. Third-generation DNA sequencing. Ion PGM system from Life Technologies Corporation (Carlsbad, CA). PacBio RS II SMRT
system is based on single-molecule, real-time (SMRT) DNA sequencing technology from Pacific Biosciences (Menlo Park, CA).
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abundance of your organism(s) or metabolic pathway(s) of interest. If
your metagenome or metatranscriptome is of a relatively low complexity, you can use available genome sequences to evaluate the coverage
needed.48 For a metatranscriptome, you’ll have to adapt the sequencing
coverage if your focus is the most abundant transcripts or the rare transcripts. It has been shown that millions of 16S rRNA reads do not appreciably increase the extracted information and that a cost-efficient read
number is sufficient to discriminate adjacent sites.1,9 In contrast, during
the analysis of the stool microbiome of 100 individuals, increasing the
depth of sequencing from 4.5 to 11.7 Gb on average per sample, the human fecal gene catalog increased from 3.349 to 5.1 million nonredundant
microbial genes,8 respectively.
Multiplexing of samples has both decreased the cost and allowed to
control the number of reads for batch of samples. This approach tags
each sample with a unique barcode that is also sequenced. The post-sequencing computing pipeline allows the reads to be binned based on
the sample of origin, allowing many samples to be simultaneously se
quenced.50 Additional hidden costs that should be kept in mind are li
brary construction required for preparing the DNA to be sequenced, kits,
consumables, labor, instrument initial costs and maintenance, personnel
support, indirect cost rate, etc. Further additional costs might be associated with the bioinformatics required for filtering low-quality reads, sequence assembly for pair-ended reads, removing human origin contaminating reads, providing raw or processed reads to your laborator y, and
data submission. It’s a discussion that you may want to have upfront with
your collaborator and/or your sequencing facility of choice.
Read quality is always a parameter to take into account. One of the
most common metrics for assessing sequence quality data is the Q score.
Low Q scores (below 20) can lead to increase false-positive variants. Q20,
which represents an error probability of 1%, is an accepted community
standard for a high-quality base, similar to the expectation of Sangerbased DNA sequencing. As the technologies improve, we can expect
quality standard of Q30 (error probability of 1–1000) and above to be the
norm.
Data Storage and Data Analysis
Next-generation sequencing moved us from the kilo- and megabytes size
files to the mega- and terabytes size file world. Although this might not
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be of great importance when you are performing a single metagenomics
experiment, it can quickly become an issue in large-scale studies. To put
this in context, the HMP 16S rRNA-targeted approach generated about
250 megabases, while the shotgun sequencing approach produced over
3 terabases.8 While the former can be handled on a traditional computer,
the latter requires a lot of computing time (or CPU hours) on a computer
or computer cluster with another class of technical specifications. An alternative is the use of remote or cloud computing power through virtual
machine approaches.51 Be sure that the data and related information is
secured during transfer and in the cloud.
When focusing on 16S rRNA-targeted approach, the availability of
packaged analysis pipelines greatly facilitates the process. Mothur and
QIIME are not the only available options, although both have shown consistency of improvement and regular updates over the last few years.52,53
These pipelines include statistical tools that allow a complete analysis of
your dataset including your metadata. As we have been focusing on the
quality of the input and output of metagenomic analysis, it is important
to note that the denoising step is a crucial step that can increase microbial diversity (up to a meaningless amount if read quality filtering and
chimera removal are not performed) or restrict the observed diversity
based on the settings.54 There is a balance that must be attained; however, this can be a bit more difficult to achieve when conducting the investigation of an understudied microbiome.
Whole genome shotgun sequencing leads to the information about
the DNA and/or the RNA in the sample. The applications can and have
been numerous. The focus might be on metabolism, discovering new
metabolic or antibiotic pathways, phylogeny, site comparison, the distribution of single nucleotide polymorphism in the microbiome(s), the
influence of cancer or antibiotic treatment, the behavioral effect, etc.
From the same dataset, phylogenetic placement of the microbiota pres
ent in the sample can be obtained from the gene pool instead of the 16S
rRNA gene as their relative abundance in the dataset is low.8,55,56 Pack
aged analysis pipelines including statistical tools are available to down
load or as an Internet resource. An incomplete list of those resources includes CAMERA,57 EBI metagenomics,58 IMG/M,59 MEGAN,60 METAREP,61
and MG-RAST.62 For all metagenomics applications, commercial software
replace or complement freely available tools.
All bioinformatics tools rely on databases to add layers of information,
from phylogeny to function. While some are based on only one technology (such as the gene catalogs from METAhit and the HMP), others have
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evolved through generations of approaches and technological advancements such as COG,63 KEGG,64 GenBank, and all the other international
depositories.65 The lack of standardization, inconsistent annotation, and
the different technologies leading to specific errors unknown to the investigator create some challenges. Curated databases are attempts to
limit those issues and often decrease the dataset size by removing information (e.g., sequences) not relevant to the focus in question. Some of
these databases include CAZy,66 Greengenes,67 HOMD,14 and MetaCyc.68
The power of additional layers of information is in their enrichment of
the content that we can derive from a dataset. However, we should keep
in mind that part of the information from the dataset is unavailable as it
did not perfectly match to a previously obtained dataset. With the diversity of microbial strains yet to be sequenced, the answer to your scientific question might reside in the conserved proteins without associated
function, or gene(s) or gene set that have never been deposited before.
Data and Publication
Any metagenomic project should include a plan for sharing the data
collected to the scientific community, including sequence data and
metadata. The International Nucleotide Sequence Database Collaboration (INSDC, http://insdc.org ) hosts some of the repositories for the
collection and dissemination of nucleic acid datasets. INSDC is a joint
effort hosting the following computerized databases: DNA Data Bank
of Japan (Japan), GenBank (USA), and the European Nucleotide Archive
(based in the United Kingdom).69
The need to archive well-defined contextual metadata has been rec
ognized by the community, leading to the creation of the Genomic Standards Consortium. Their mission is to work toward: 1) the implementation
of new genomic standards, 2) methods of capturing and exchanging the
information captured in these standards, and 3) harmonization of information collection and analysis efforts across the wider genomics community.70 From this effort arose the creation of minimum information requirement for both genomes and metadata to be submitted to the journal
and sequence repositories. The MIGS (minimal information about a genome sequence), MIMS (minimal information about metagenome sequence), MIMARKS (minimal information about marker gene sequence),
and MIxS (minimum Information about any (X) sequence) specifications
are checklists that both standardize and enhance our ability to further
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analyze datasets for either training or complementary analysis.71,72 The
adoption of such standards elevates the quality, accessibility, and utility
of the information collected by the data repository.
As of yet, there is no standard format to present how the data was analyzed. In the best interests of all, the format should include the meth
ods, tools, and parameters used in the analysis. One option is to make
the information available as an online appendix to the published article.
There is no such thing as pressing a button and getting the completed
analysis. Professional scientists, students, and citizen scientists encoun
ter the same issues. Similar standards of high quality should be put into
service for the benefits of the biosphere.
Let’s Talk About the Status Quo
In science, the status quo, the existing state of affairs, and the dogma,
the established opinion and doctrine, often go hand in hand. Every time
a new technology challenges, the status quo resistance occurs, not al
ways in the most constructive of ways. It is not our place to choose for
you where you stand in the debate regarding the progresses supported
by metagenomic approaches. One clear progress is the flow of data. It
creates more statistical power to discriminate the aspect(s) of your hy
pothesis validation, and offers opportunities for validating previously
published hypothesis and for hypothesis generation.
What about the “old data,” the ones published using more restricted
or better focused analyses? There is no current methodology that can
yet replace quantitative PCR for detecting the relative abundance of host
versus microbial genetic abundance. The previous approaches for cultivation-independent analyses are here to guide us by facilitating the analysis and providing the trampoline needed for the next discovery. The
high dimensionality of the datasets is potentially a challenge, but it also
brings new opportunities to create a validated system biology approach
to better understand biological function.
The conceptual and practical details are project specific and all part
ners should be part of the discussion and project building (primary in
vestigator, co-investigators, statistician, bioinformatician, core facilities,
providers, suppliers, IT department, etc.). This is a call to students, pro
fessional scientists, and citizen scientists alike, to create new datasets and
tools that are needed. Please research, share, and disseminate.
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